Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa

Individuals with anorexia nervosa (AN) and bulimia nervosa (BN) have alterations of measures of serotonin (5-HT) and dopamine (DA) function, which persist after long-term recovery and are associated with elevated harm avoidance (HA), a measure of anxiety and behavioral inhibition. Based on theories that 5-HT is an aversive motivational system that may oppose a DA-related appetitive system, we explored interactions of positron emission tomography (PET) radioligand measures that reflect portions of these systems. Twenty-seven individuals recovered (REC) from eating disorders (EDs) (7 AN-BN, 11 AN, 9 BN) and nine control women (CW) were analyzed for correlations between [C-11]McN5652 and [C-11]raclopride binding. There was a significant positive correlation between [C-11]McN5652 binding potential (BPnon displaceable(ND)) and [C-11]Raclopride BPND for the dorsal caudate, antero-ventral striatum (AVS), middle caudate, and ventral and dorsal putamen. No significant correlations were found in CW. [C-11]Raclopride BPND, but not [C-11]McN5652 BPND, was significantly related to HA in REC EDs. A linear regression analysis showed that the interaction between [C-11]McN5652 BPND and [C-11]raclopride BPND in the dorsal putamen significantly predicted HA. This is the first study using PET and the radioligands [C-11]McN5652 and [C-11]raclopride to show a direct relationship between 5-HT transporter and striatal DA D2/D3 receptor binding in humans, supporting the possibility that 5-HT and DA interactions contribute to HA behaviors in EDs. (C) 2012 Elsevier Ireland Ltd. All rights reserved.